▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1946 by analyst upside · 2026-06-27
LRN
Stride, Inc.
Consumer Defensive · Market Cap $4B · P/E 13.5x
ANALYST PRICE TARGET
+30.3%
implied upside to consensus target
Current Price $87.12
Consensus Target $113.5
Bull Target $125.0
Bear Target $102.0
Analysts Covering 2
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
1
Hold
1
Sell
0
52-Week Low $60.61
52-Week High $171.17
YTD Return +34.8%
FUNDAMENTALS
Market Cap $4B
P/E Ratio (TTM) 13.5x
Forward P/E 9.9x
EPS (TTM) $6.46
PEG Ratio 0.48
Dividend Yield N/A
Revenue (TTM) $2.5B
Profit Margin 12.2%
52-WEEK RANGE
52-Week Low $60.61
52-Week High $171.17
Current Price $87.12
Bear Target $102.0
Bull Target $125.0
● Now $87.12 ● Target $113.5
TRADING DATA
Avg Volume 791K
YTD Return +34.8%
Analyst Count 2
Consensus Buy
Upside to Target +30.3%
Last Updated 2026-06-27

ANALYST SUMMARY

Stride, Inc. (LRN) is currently trading at $87.12 with a Wall Street consensus price target of $113.5, implying potential upside of 30.3% over the next 12 months. 2 analysts currently cover LRN, with a consensus rating of Buy — 67% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $125.0, while the most cautious has a target of $102.0.

LRN operates in the Consumer Defensive sector with a market capitalisation of $4B. The stock is up 34.8% year-to-date and is currently trading near the lower end of its 52-week range of $60.61 – $171.17.

SIMILAR STOCKS

Other Consumer Defensive stocks with comparable size and valuation.

POST +36.8%
Post Holdings, Inc.
$4B · P/E 15.0x · Buy
PRDO +32.0%
Perdoceo Education Corporation
$2B · P/E 12.6x · Strong Buy
CVSA +22.5%
Covista Inc.
$4B · P/E 18.6x · Buy
INGR +26.0%
Ingredion Incorporated
$6B · P/E 9.3x · Buy
PPC +34.6%
Pilgrim's Pride Corporation
$7B · P/E 7.2x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for LRN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barrington Research — Reiterated
Outperform → Outperform 2026-04-16 Building track record
Canaccord Genuity — Reiterated
Buy → Buy 2026-01-28 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-01-28 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-01-21 Building track record
Morgan Stanley — Reiterated
Equal-Weight → Equal-Weight 2025-12-17 Building track record
BMO Capital — Reiterated
Market Perform → Market Perform 2025-11-07 Building track record
Canaccord Genuity — Reiterated
Buy → Buy 2025-10-29 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2025-10-29 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →